Table 2.
Patient characteristics during ICU stay
| Characteristics | Overall cohort (n = 1313) | Immuno-compromised patients (n = 271) | Non-immuno-compromised patients (n = 1042) |
|---|---|---|---|
| Invasive devices and procedures | |||
| Central venous catheter | 804 (61.2) | 177 (65.3) | 627 (60.2) |
| Duration (days) | 10 (6–20) | 9 (5–20) | 11 (6–22) |
| Arterial catheter | 944 (71.9) | 198 (73.1) | 746 (71.6) |
| Duration (days) | 10 (6–18) | 9 (5–14) | 10 (6–20) |
| Renal replacement therapy | 137 (10.4) | 24 (8.9) | 113 (10.8) |
| Invasive mechanical ventilation | 666 (50.7) | 122 (45.0) | 544 (52.2) |
| Duration (days) | 8 (3–18) | 7 (3–14) | 9 (3–19) |
| Treatments | |||
| Antibiotics | 1127 (85.8) | 237 (87.5) | 890 (85.4) |
| Duration (days) | 5 (3–7)1 | 5 (3–8)2 | 5 (3–7)3 |
| Parenteral nutrition | 111 (8.5) | 18 (6.6) | 93 (8.9) |
| Transfusions | 326 (24.8) | 93 (34.3) | 233 (22.4) |
| Corticosteroids | 615 (46.8) | 153 (56.4) | 462 (44.3) |
| Prednisone dose equivalence (mg) | 60 (40–130)4 | 50 (40–100)5 | 62 (40–130)6 |
Values are as number (%) or median (25th to 75th percentiles)
ICU intensive care unit
Missing values: 19, 21, 38, 431, 59, 622